Research Groups

Early Detection and Prevention - Prevention and Implementation Group

Previous Publications - All Publications 2017-2013

1. Rodriguez A. C., Avila C., Herrero R., Hildesheim A., Sherman M. E., Burk R. D., Morales J., Alfaro M., Guillen D., Trejos M. E., Vargas R. M., Torres G., Schiffman M. (2017) Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort Int J Cancer; 140(8):1926-1934. PMID: 28120391

2. Huang J., Zagai U., Hallmans G., Nyren O., Engstrand L., Stolzenberg-Solomon R., Duell E. J., Overvad K., Katzke V. A., Kaaks R., Jenab M., Park J. Y., Murillo R., Trichopoulou A., Lagiou P., Bamia C., Bradbury K. E., Riboli E., Aune D., Tsilidis K. K., Capella G., Agudo A., Krogh V., Palli D., Panico S., Weiderpass E., Tjonneland A., Olsen A., Martinez B., Redondo-Sanchez D., Chirlaque M. D., Hm Peeters P., Regner S., Lindkvist B., Naccarati A., Ardanaz E., Larranaga N., Boutron-Ruault M. C., Rebours V., Barre A., Bueno-de-Mesquita H. B., Ye W. (2017) Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study Int J Cancer; 140(8):1727-1735. PMID: 28032715

3. Denny L., de Sanjose S., Mutebi M., Anderson B. O., Kim J., Jeronimo J., Herrero R., Yeates K., Ginsburg O., Sankaranarayanan R. (2017) Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries Lancet; 389(10071):861-870. PMID: 27814963

4. Ginindza T. G., Dlamini X., Almonte M., Herrero R., Jolly P. E., Tsoka-Gwegweni J. M., Weiderpass E., Broutet N., Sartorius B. (2017) Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland PLoS ONE; 12(1):e0170189. PMID: 28114325

5. Muwonge R., Ngo Mbus L., Ngoma T., Gombe Mbalawa C., Dolo A., da Ganda Manuel M., Nouhou H., Nacoulma M., Mwaiselage J., Koulibaly M., Bayo S., Nsonde Malanda J., De Vuyst H., Herrero R., Sankaranarayanan R., Keita N. (2016) Socio-demographic and reproductive determinants of cervical neoplasia in seven sub-Sahara African countries Cancer Causes Control; 27(12):1437-1446. PMID: 27822586

6. Lesseur C., Diergaarde B., Olshan A. F., Wunsch-Filho V., Ness A. R., Liu G., Lacko M., Eluf-Neto J., Franceschi S., Lagiou P., Macfarlane G. J., Richiardi L., Boccia S., Polesel J., Kjaerheim K., Zaridze D., Johansson M., Menezes A. M., Curado M. P., Robinson M., Ahrens W., Canova C., Znaor A., Castellsague X., Conway D. I., Holcatova I., Mates D., Vilensky M., Healy C. M., Szeszenia-Dabrowska N., Fabianova E., Lissowska J., Grandis J. R., Weissler M. C., Tajara E. H., Nunes F. D., de Carvalho M. B., Thomas S., Hung R. J., Peters W. H., Herrero R., Cadoni G., Bueno-de-Mesquita H. B., Steffen A., Agudo A., Shangina O., Xiao X., Gaborieau V., Chabrier A., Anantharaman D., Boffetta P., Amos C. I., McKay J. D., Brennan P. (2016) Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer Nat Genet; 48(12):1544-1550. PMID: 27749845

7. Costas L., Benavente Y., Olmedo-Requena R., Casabonne D., Robles C., Gonzalez-Barca E. M., de la Banda E., Alonso E., Aymerich M., Tardon A., Marcos-Gragera R., Gimeno-Vazquez E., Gomez-Acebo I., Papantoniou K., Castano-Vinyals G., Aragones N., Pollan M., Kogevinas M., de Sanjose S. (2016) Night shift work and chronic lymphocytic leukemia in the MCC-Spain case-control study Int J Cancer; 139(9):1994-2000. PMID: 27416551

8. Clifford G. M., de Vuyst H., Tenet V., Plummer M., Tully S., Franceschi S. (2016) Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa J Acquir Immune Defic Syndr; 73(3):332-339. PMID: 27331659

9. Huseinovic E., Winkvist A., Slimani N., Park M. K., Freisling H., Boeing H., Buckland G., Schwingshackl L., Weiderpass E., Rostgaard-Hansen A. L., Tjonneland A., Affret A., Boutron-Ruault M. C., Fagherazzi G., Katzke V., Kuhn T., Naska A., Orfanos P., Trichopoulou A., Pala V., Palli D., Ricceri F., Santucci de Magistris M., Tumino R., Engeset D., Enget T., Skeie G., Barricarte A., Bonet C. B., Chirlaque M. D., Amiano P., Quiros J. R., Sanchez M. J., Dias J. A., Drake I., Wennberg M., Boer J., Ocke M. C., Verschuren W., Lassale C., Perez-Cornago A., Riboli E., Ward H., Forslund H. B. (2016) Meal patterns across ten European countries - results from the European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study Public Health Nutr; 19(15):2769-80. PMID: 27194183

10. Murillo R., Herrero R., Sierra M. S., Forman D. (2016) Cervical cancer in Central and South America: Burden of disease and status of disease control Cancer Epidemiol; S121-s130. PMID: 27678314

11. Combita A. L., Gheit T., Gonzalez P., Puerto D., Murillo R. H., Montoya L., Vorsters A., Van Keer S., Van Damme P., Tommasino M., Hernandez-Suarez G., Sanchez L., Herrero R., Wiesner C. (2016) Comparison between Urine and Cervical Samples for HPV DNA Detection and Typing in Young Women in Colombia Cancer Prev Res (Phila); 9(9):766-71. PMID: 27417431

12. Talarico S., Safaeian M., Gonzalez P., Hildesheim A., Herrero R., Porras C., Cortes B., Larson A., Fang F. C., Salama N. R. (2016) Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage Helicobacter; 21(4):325-33. PMID: 26667241

13. Negulescu R. A., Catarino R., De Vuyst H., Undurraga-Malinverno M., Meyer-Hamme U., Alec M., Campana A., Vassilakos P., Petignat P. (2016) Web-based instrument to assess skills in visual inspection of the cervix among healthcare providers Int J Gynaecol Obstet; 134(1):107-13. PMID: 27126908

14. Bruni L., Diaz M., Barrionuevo-Rosas L., Herrero R., Bray F., Bosch F. X., de Sanjose S., Castellsague X. (2016) Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis Lancet Glob Health; 4(7):e453-63. PMID: 27340003

15. Berthiller J., Straif K., Agudo A., Ahrens W., Bezerra Dos Santos A., Boccia S., Cadoni G., Canova C., Castellsague X., Chen C., Conway D., Curado M. P., Dal Maso L., Daudt A. W., Fabianova E., Fernandez L., Franceschi S., Fukuyama E. E., Hayes R. B., Healy C., Herrero R., Holcatova I., Kelsey K., Kjaerheim K., Koifman S., Lagiou P., La Vecchia C., Lazarus P., Levi F., Lissowska J., Macfarlane T., Mates D., McClean M., Menezes A., Merletti F., Morgenstern H., Muscat J., Olshan A. F., Purdue M., Ramroth H., Rudnai P., Schwartz S. M., Serraino D., Shangina O., Smith E., Sturgis E. M., Szeszenia-Dabrowska N., Thomson P., Vaughan T. L., Vilensky M., Wei Q., Winn D. M., Wunsch-Filho V., Zhang Z. F., Znaor A., Ferro G., Brennan P., Boffetta P., Hashibe M., Lee Y. C. (2016) Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis Int J Epidemiol; 45(3):835-45. PMID: 26228584

16. Santesso N., Mustafa R. A., Schunemann H. J., Arbyn M., Blumenthal P. D., Cain J., Chirenje M., Denny L., De Vuyst H., Eckert L. O., Forhan S. E., Franco E. L., Gage J. C., Garcia F., Herrero R., Jeronimo J., Lu E. R., Luciani S., Quek S. C., Sankaranarayanan R., Tsu V., Broutet N. (2016) World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer Int J Gynaecol Obstet; 132(3):252-8. PMID: 26868062

17. Harari A., Chen Z., Rodriguez A. C., Hildesheim A., Porras C., Herrero R., Wacholder S., Panagiotou O. A., Befano B., Burk R. D., Schiffman M. (2016) Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections J Infect Dis; 213(6):939-47. PMID: 26518044

18. Murillo R., Diaz S., Perry F., Poveda C., Pineros M., Sanchez O., Buitrago L., Gamboa O., Lozano T., Yu H., Wang C. Y., Duggan C., Thomas D. B., Anderson B. O. (2016) Increased breast cancer screening and downstaging in Colombian women: A randomized trial of opportunistic breast-screening Int J Cancer; 138(3):705-13. PMID: 26264446

19. Hernandez-Avila M., Torres-Ibarra L., Stanley M., Salmeron J., Cruz-Valdez A., Munoz N., Herrero R., Villasenor-Ruiz I. F., Lazcano-Ponce E. (2016) Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes Hum Vaccin Immunother; 12(1):30-8. PMID: 26211489

20. Beachler D. C., Kreimer A. R., Schiffman M., Herrero R., Wacholder S., Rodriguez A. C., Lowy D. R., Porras C., Schiller J. T., Quint W., Jimenez S., Safaeian M., Struijk L., Schussler J., Hildesheim A., Gonzalez P. (2016) Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection J Natl Cancer Inst; 108(1):. PMID: 26467666

21. Villain P., Gonzalez P., Almonte M., Franceschi S., Dillner J., Anttila A., Park J. Y., De Vuyst H., Herrero R. (2015) European Code against Cancer 4th Edition: Infections and Cancer Cancer Epidemiol; S120-38. PMID: 26589774

22. Schuz J., Espina C., Villain P., Herrero R., Leon M. E., Minozzi S., Romieu I., Segnan N., Wardle J., Wiseman M., Belardelli F., Bettcher D., Cavalli F., Galea G., Lenoir G., Martin-Moreno J. M., Nicula F. A., Olsen J. H., Patnick J., Primic-Zakelj M., Puska P., van Leeuwen F. E., Wiestler O., Zatonski W. (2015) European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk Cancer Epidemiol; S1-10. PMID: 26164654

23. Minozzi S., Armaroli P., Espina C., Villain P., Wiseman M., Schuz J., Segnan N. (2015) European Code against Cancer 4th Edition: Process of reviewing the scientific evidence and revising the recommendations Cancer Epidemiol; S11-9. PMID: 26439654

24. Armaroli P., Villain P., Suonio E., Almonte M., Anttila A., Atkin W. S., Dean P. B., de Koning H. J., Dillner L., Herrero R., Kuipers E. J., Lansdorp-Vogelaar I., Minozzi S., Paci E., Regula J., Tornberg S., Segnan N. (2015) European Code against Cancer, 4th Edition: Cancer screening Cancer Epidemiol; S139-52. PMID: 26596722

25. Shimakawa Y., Lemoine M., Bottomley C., Njai H. F., Ndow G., Jatta A., Tamba S., Bojang L., Taal M., Nyan O., D\'Alessandro U., Njie R., Thursz M., Hall A. J. (2015) Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia Liver Int; 35(10):2318-26. PMID: 25728498

26. Bryant D., Hibbitts S., Almonte M., Tristram A., Fiander A., Powell N. (2015) Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women Journal of Clinical Virology; 66-71. PMID: 25866341

27. von Karsa Lawrence, Arbyn Marc, De Vuyst Hugo, Dillner Joakim, Dillner Lena, Franceschi Silvia, Patnick Julietta, Ronco Guglielmo, Segnan Nereo, Suonio Eero, Törnberg Sven, Anttila Ahti (2015) European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination Papillomavirus Research; 22-31.

28. Toporcov T.N., Znaor A., Zhang Z.F., Yu G.P., Winn D.M., Wei Q., Vilensky M., Vaughan T., Thomson P., Talamini R., Szeszenia-Dabrowska N., Sturgis E.M., Smith E., Shangina O., Schwartz S.M., Schantz S., Rudnai P., Richiardi L., Ramroth H., Purdue M.P., Olshan A.F., Eluf-Neto J., Muscat J., Moyses R.A., Morgenstern H., Menezes A., McClean M., Matsuo K., Mates D., Macfarlane T.V., Lissowska J., Levi F., Lazarus P., La Vecchia C., Lagiou P., Koifman S., Kjaerheim K., Kelsey K., Holcatova I., Herrero R., Healy C., Hayes R.B., Franceschi S., Fernandez L., Fabianova E., Daudt A.W., Curioni O.A., Maso L.D., Curado M.P., Conway D.I., Chen C., Castellsague X., Canova C., Cadoni G., Brennan P., Boccia S., Antunes J.L., Ahrens W., Agudo A., Boffetta P., Hashibe M., Lee Y.C., Filho V.W. (2015) Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium Int. J Epidemiol; 44(1):169-185. PMID: 25613428

29. Quesada P., Whitby D., Benavente Y., Miley W., Labo N., Chichareon S., Trong N., Shin H.R., Anh P.T., Thomas J., Matos E., Herrero R., Munoz N., Molano M., Franceschi S., de Sanjose S. (2015) Hepatitis C virus seroprevalence in the general female population from 8 countries J Clin. Virol; 89-93. PMID: 26071344

30. Porras C., Hildesheim A., Gonzalez P., Schiffman M., Rodriguez A.C., Wacholder S., Jimenez S., Quint W., Guillen D., Kreimer A.R., Herrero R. (2015) Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing J Natl Cancer Inst; 107(1):400. PMID: 25479804

31. Park M.K., Park J.Y., Nicolas G., Paik H.Y., Kim J., Slimani N. (2015) Adapting a standardised international 24 h dietary recall methodology (GloboDiet software) for research and dietary surveillance in Korea Br. J Nutr; 113(11):1810-1818. PMID: 25899045

32. Panagiotou O.A., Befano B.L., Gonzalez P., Rodriguez A.C., Herrero R., Schiller J.T., Kreimer A.R., Schiffman M., Hildesheim A., Wilcox A.J., Wacholder S. (2015) Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial BMJ; h4358. PMID: 26346155

33. Lowy D.R., Herrero R., Hildesheim A., Participants in the IARC/NCI workshop on Primary Endpoints for Prophylactic HPV Vaccine Trials (2015) Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging Lancet Oncol; 16(5):e226-e233. PMID: 25943067

34. Kreimer A.R., Struyf F., Del Rosario-Raymundo M.R., Hildesheim A., Skinner S.R., Wacholder S., Garland S.M., Herrero R., David M.P., Wheeler C.M. (2015) Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials Lancet Oncol; 16(7):775-786. PMID: 26071347

35. Herrero R., Gonzalez P., Markowitz L.E. (2015) Present status of human papillomavirus vaccine development and implementation Lancet Oncol; 16(5):e206-e216. PMID: 25943065

36. Gonzalez P., Hildesheim A., Herrero R., Katki H., Wacholder S., Porras C., Safaeian M., Jimenez S., Darragh T.M., Cortes B., Befano B., Schiffman M., Carvajal L., Palefsky J., Schiller J., Ocampo R., Schussler J., Lowy D., Guillen D., Stoler M.H., Quint W., Morales J., Avila C., Rodriguez A.C., Kreimer A.R. (2015) Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica Vaccine; 33(18):2141-2151. PMID: 25796338

37. de Batlle J., Ferrari P., Chajes V., Park J.Y., Slimani N., McKenzie F., Overvad K., Roswall N., Tjonneland A., Boutron-Ruault M.C., Clavel-Chapelon F., Fagherazzi G., Katzke V., Kaaks R., Bergmann M.M., Trichopoulou A., Lagiou P., Trichopoulos D., Palli D., Sieri S., Panico S., Tumino R., Vineis P., Bueno-de-Mesquita H.B., Peeters P.H., Hjartaker A., Engeset D., Weiderpass E., Sanchez S., Travier N., Sanchez M.J., Amiano P., Chirlaque M.D., Barricarte Gurrea A., Khaw K.T., Key T.J., Bradbury K.E., Ericson U., Sonestedt E., Van Guelpen B., Schneede J., Riboli E., Romieu I. (2015) Dietary folate intake and breast cancer risk: European prospective investigation into cancer and nutrition J Natl Cancer Inst; 107(1):367. PMID: 25505228

38. Conway D.I., Brenner D.R., McMahon A.D., Macpherson L.M., Agudo A., Ahrens W., Bosetti C., Brenner H., Castellsague X., Chen C., Curado M.P., Curioni O.A., Dal Maso L., Daudt A.W., de Gois Filho J.F., D\'Souza G., Edefonti V., Fabianova E., Fernandez L., Franceschi S., Gillison M., Hayes R.B., Healy C.M., Herrero R., Holcatova I., Jayaprakash V., Kelsey K., Kjaerheim K., Koifman S., La Vecchia C., Lagiou P., Lazarus P., Levi F., Lissowska J., Luce D., Macfarlane T.V., Mates D., Matos E., McClean M., Menezes A.M., Menvielle G., Merletti F., Morgenstern H., Moysich K., Muller H., Muscat J., Olshan A.F., Purdue M.P., Ramroth H., Richiardi L., Rudnai P., Schantz S., Schwartz S.M., Shangina O., Simonato L., Smith E., Stucker I., Sturgis E.M., Szeszenia-Dabrowska N., Talamini R., Thomson P., Vaughan T.L., Wei Q., Winn D.M., Wunsch-Filho V., Yu G.P., Zhang Z.F., Zheng T., Znaor A., Boffetta P., Chuang S.C., Ghodrat M., Amy Lee Y.C., Hashibe M., Brennan P. (2015) Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries Int J Cancer; 136(5):1125-1139. PMID: 24996155

39. Arrossi S., Thouyaret L., Laudi R., Marin O., Ramirez J., Paolino M., Herrero R., Campanera A. (2015) Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina Int. J Cancer; 137(7):1709-1718. PMID: 25807897

40. Arrossi S., Thouyaret L., Herrero R., Campanera A., Magdaleno A., Cuberli M., Barletta P., Laudi R., Orellana L. (2015) Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial Lancet Glob. Health; 3(2):e85-e94. PMID: 25617202

41. Almonte M., Ferreccio C., Luciani S., Gonzales M., Delgado J.M., Santos C., Alvarez M., Cuzick J., Sasieni P. (2015) Visual Inspection after Acetic Acid (VIA) Is Highly Heterogeneous in Primary Cervical Screening in Amazonian Peru PLoS. One; 10(1):e0115355. PMID: 25635965

42. Ronco G., Dillner J., Elfstrom K.M., Tunesi S., Snijders P.J., Arbyn M., Kitchener H., Segnan N., Gilham C., Giorgi-Rossi P., Berkhof J., Peto J., Meijer C.J. (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Lancet; 383(9916):524-532. PMID: 24192252

43. Rollan A., Arab J.P., Camargo M.C., Candia R., Harris P., Ferreccio C., Rabkin C.S., Gana J.C., Cortes P., Herrero R., Duran L., Garcia A., Toledo C., Espino A., Lustig N., Sarfatis A., Figueroa C., Torres J., Riquelme A. (2014) Management of Helicobacter pylori infection in Latin America: A Delphi technique-based consensus World J Gastroenterol; 20(31):10969-10983. PMID: 25152601

44. Robbins H.A., Waterboer T., Porras C., Kemp T.J., Pawlita M., Rodriguez A.C., Wacholder S., Gonzalez P., Schiller J.T., Lowy D.R., Esser M., Matys K., Poncelet S., Herrero R., Hildesheim A., Pinto L.A., Safaeian M. (2014) Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay Hum. Vaccin. Immunother; 10(10):2965-2974. PMID: 25483632

45. Robbins H.A., Li Y., Porras C., Pawlita M., Ghosh A., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Gonzalez P., Schiller J., Lowy D., Esser M., Matys K., Quint W., Van Doorn L.J., Herrero R., Pinto L.A., Hildesheim A., Waterboer T., Safaeian M. (2014) Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus BMC. Infect Dis; 120. PMID: 24588945

46. Robbins H.A., Kemp T.J., Porras C., Rodriguez A.C., Schiffman M., Wacholder S., Gonzalez P., Schiller J., Lowy D., Poncelet S., Esser M., Matys K., Hildesheim A., Pinto L.A., Herrero R., Safaeian M. (2014) Comparison of antibody responses to human papillomavirus vaccination as measured by three assays Front Oncol; 328. PMID: 24455487

47. Park J.Y., von Karsa L., Herrero R. (2014) Prevention strategies for gastric cancer: a global perspective Clin Endosc; 47(6):478-489. PMID: 25505712

48. Leoncini E., Ricciardi W., Cadoni G., Arzani D., Petrelli L., Paludetti G., Brennan P., Luce D., Stucker I., Matsuo K., Talamini R., La Vecchia C., Olshan A.F., Winn D.M., Herrero R., Franceschi S., Castellsague X., Muscat J., Morgenstern H., Zhang Z.F., Levi F., Dal Maso L., Kelsey K., McClean M., Vaughan T.L., Lazarus P., Purdue M.P., Hayes R.B., Chen C., Schwartz S.M., Shangina O., Koifman S., Ahrens W., Matos E., Lagiou P., Lissowska J., Szeszenia-Dabrowska N., Fernandez L., Menezes A., Agudo A., Daudt A.W., Richiardi L., Kjaerheim K., Mates D., Betka J., Yu G.P., Schantz S., Simonato L., Brenner H., Conway D.I., Macfarlane T.V., Thomson P., Fabianova E., Znaor A., Rudnai P., Healy C., Boffetta P., Chuang S.C., Lee Y.C., Hashibe M., Boccia S. (2014) Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium Eur J Epidemiol; 29(1):35-48. PMID: 24271556

49. Lazcano-Ponce E., Stanley M., Munoz N., Torres L., Cruz-Valdez A., Salmeron J., Rojas R., Herrero R., Hernandez-Avila M. (2014) Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months Vaccine; 32(6):725-732. PMID: 24355090

50. Lang Kuhs K.A., Porras C., Schiller J.T., Rodriguez A.C., Schiffman M., Gonzalez P., Wacholder S., Ghosh A., Li Y., Lowy D.R., Kreimer A.R., Poncelet S., Schussler J., Quint W., Van Doorn L.J., Sherman M.E., Sidawy M., Herrero R., Hildesheim A., Safaeian M. (2014) Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates Am. J. Epidemiol; 180(6):599-607. PMID: 25139208

51. Lang Kuhs K.A., Gonzalez P., Rodriguez A.C., Van Doorn L.J., Schiffman M., Struijk L., Chen S., Quint W., Lowy D.R., Porras C., DelVecchio C., Jimenez S., Safaeian M., Schiller J.T., Wacholder S., Herrero R., Hildesheim A., Kreimer A.R. (2014) Reduced Prevalence of Vulvar HPV16/18 Infection Among Women Who Received the HPV16/18 Bivalent Vaccine: A Nested Analysis Within the Costa Rica Vaccine Trial J Infect Dis; 210(12):1890-1899. PMID: 24958910

52. Herrero R., Parsonnet J., Greenberg E.R. (2014) Prevention of gastric cancer JAMA; 312(12):1197-1198. PMID: 25247512

53. Herrero R., Park J.Y., Forman D. (2014) The fight against gastric cancer - the IARC Working Group report Best. Pract. Res Clin Gastroenterol; 28(6):1107-1114. PMID: 25439075

54. Guevara E., Baena A., Almonte M., Salaza J.E., Gaviria A., Sanchez G.I. (2014) Reproducibilidad en la lectura de un set de placas de citología cérvico-uterinas en cuatro centros especializados de Medellín, Antioquia Revista Facultad Nacional de Salud Publica; 32(2):54-60.

55. De Vuyst H., Mugo N.R., Franceschi S., McKenzie K., Tenet V., Njoroge J., Rana F.S., Sakr S.R., Snijders P.J., Chung M.H. (2014) Residual Disease and HPV Persistence after Cryotherapy for Cervical Intraepithelial Neoplasia Grade 2/3 in HIV-Positive Women in Kenya PLoS ONE; 9(10):e111037. PMID: 25343563

56. Combes J.D., Pawlita M., Waterboer T., Hammouda D., Rajkumar T., Vanhems P., Snijders P., Herrero R., Franceschi S., Clifford G. (2014) Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer Int J Cancer; 135(10):2453-2461. PMID: 24729277

57. Chen A.A., Heideman D.A., Boon D., Chen Z., Burk R.D., De Vuyst H., Gheit T., Snijders P.J., Tommasino M., Franceschi S., Clifford G.M. (2014) Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer Virology; 356-362. PMID: 24314666

58. Campos N.G., Burger E.A., Sy S., Sharma M., Schiffman M., Rodriguez A.C., Hildesheim A., Herrero R., Kim J.J. (2014) An updated natural history model of cervical cancer: derivation of model parameters Am J Epidemiol; 180(5):545-555. PMID: 25081182

59. Bedoya A.M., Tate D.J., Baena A., Cordoba C.M., Borrero M., Pareja R., Rojas F., Patterson J.R., Herrero R., Zea A.H., Sanchez G.I. (2014) Immunosuppression in cervical cancer with special reference to arginase activity Gynecol. Oncol; 135(1):74-80. PMID: 25084511

60. Anantharaman D., Chabrier A., Gaborieau V., Franceschi S., Herrero R., Rajkumar T., Samant T., Mahimkar M.B., Brennan P., McKay J.D. (2014) Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India PLoS ONE; 9(2):e88240. PMID: 24505444

61. Torres J., Correa P., Ferreccio C., Hernandez-Suarez G., Herrero R., Cavazza-Porro M., Dominguez R., Morgan D. (2013) Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America Cancer Causes Control; 24(2):249-256. PMID: 23224271 http://down

62. Safaeian M., Porras C., Pan Y., Kreimer A., Schiller J.T., Gonzalez P., Lowy D.R., Wacholder S., Schiffman M., Rodriguez A.C., Herrero R., Kemp T., Shelton G., Quint W., Van Doorn L.J., Hildesheim A., Pinto L.A. (2013) Durable antibody responses following one dose of the bivalent human papillomavirus l1 virus-like particle vaccine in the costa rica vaccine trial Cancer Prev Res. (Phila); 6(11):1242-1250. PMID: 24189371

63. Safaeian M., Kemp T.J., Pan D.Y., Porras C., Rodriguez A.C., Schiffman M., Cortes B., Katki H., Wacholder S., Schiller J.T., Gonzalez P., Penrose K., Lowy D.R., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Pinto L.A. (2013) Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial Hum Vaccin. Immunother; 9(7):1399-1406. PMID: 23571174

64. Rodriguez A.C., Solomon D., Herrero R., Hildesheim A., Gonzalez P., Wacholder S., Porras C., Jimenez S., Schiffman M. (2013) Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment Am. J Epidemiol; 178(5):752-760. PMID: 23843026 https://www

65. Porras C., Nodora J., Sexton R., Ferreccio C., Jimenez S., Dominguez R.L., Cook P., Anderson G., Morgan D.R., Baker L.H., Greenberg E.R., Herrero R. (2013) Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) Cancer Causes Control; 24(2):209-215. PMID: 23263777 http://down

66. Park J.Y., Forman D., Greenberg E.R., Herrero R. (2013) Helicobacter pylori Eradication in the Prevention of Gastric Cancer: Are More Trials Needed? Curr Oncol Rep; 15(6):517-525. PMID: 24101366

67. Nascimento C., De Vuyst H. (2013) Prevalence and type distribution of HPV in carcinoma and intraepithelial neoplasia of the vulva and vagina: a meta-analysis HPV Today; 12-13.

68. Morgan D.R., Torres J., Sexton R., Herrero R., Salazar-Martinez E., Greenberg E.R., Bravo L.E., Dominguez R.L., Ferreccio C., Lazcano-Ponce E.C., Meza-Montenegro M.M., Pena E.M., Pena R., Correa P., Martinez M.E., Chey W.D., Valdivieso M., Anderson G.L., Goodman G.E., Crowley J.J., Baker L.H. (2013) Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities JAMA; 309(6):578-586. PMID: 23403682

69. Lin S.W., Ghosh A., Porras C., Markt S.C., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Pinto L.A., Gonzalez P., Wentzensen N., Esser M.T., Matys K., Meuree A., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Safaeian M. (2013) HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays PLoS ONE; 8(1):e53067. PMID: 23301022

70. Lang Kuhs K.A., Gonzalez P., Struijk L., Castro F., Hildesheim A., Van Doorn L.J., Rodriguez A.C., Schiffman M., Quint W., Lowy D.R., Porras C., DelVecchio C., Katki H.A., Jimenez S., Safaeian M., Schiller J., Solomon D., Wacholder S., Herrero R., Kreimer A.R. (2013) Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica J Infect. Dis; 208(10):1643-1652. PMID: 24014882

71. Herrero R., Quint W., Hildesheim A., Gonzalez P., Struijk L., Katki H.A., Porras C., Schiffman M., Rodriguez A.C., Solomon D., Jimenez S., Schiller J.T., Lowy D.R., Van Doorn L.J., Wacholder S., Kreimer A.R. (2013) Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica PLoS ONE; 8(7):e68329. PMID: 23873171

72. Herrero R. (2013) HPV and Cervical Cancer ; .

73. De Vuyst H., Chung M.H., Baussano I., Mugo N.R., Tenet V., van Kemenade F.J., Rana F.S., Sakr S.R., Meijer C.J., Snijders P.J., Franceschi S. (2013) Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya Int. J Cancer; 133(6):1441-1446. PMID: 23444059 http://onli

74. Bedoya A.M., Jaramillo R., Baena A., Castano J., Olaya N., Zea A.H., Herrero R., Sanchez G.I. (2013) Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer Cancer Microenviron; 6(1):69-77. PMID: 22290207